An interventional study of Hypoxic-hyperoxic preconditioning and Placebo in Myocardial Reperfusion Injury, Hypoxia and Hyperoxia, sponsored by Alexander Averyanov. Completed. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-06-09.
Sponsored by Alexander Averyanov · Not applicable, Interventional, and Prevention
Coronary artery bypass grafting (CABG) with cardiopulmonary bypass is a common surgical therapy for patients suffering from coronary artery diseases. The heart is subjected to a long period of ischemia due to the occlusion of the aorta. The heavy burden of myocardial ischemia-reperfusion injury (IRI) thus induces cardiomyocyte death, which can paradoxically reduce the beneficial effect of CABG. Preconditioning by moderate hypoxia or hyperoxia serves as an effective drug-free method to increase the organism's resistance to negative effects, including IRI.
It has been firmly established that the diminished oxygen delivery to the tissues in response to hypoxia is countered by a combination of the increased regional blood flow and the enhanced functional capillary density in the microcirculation. In experimental studies, exposure to hyperoxia for a limited time before ischemia induces a low-grade systemic oxidative stress evokes a preconditioning-like effect on the myocardium and reduces the infarction area by 20%, and the number of arrhythmias after ischemia-reperfusion. One hundred twenty patients were randomly assigned into two equal groups: hypoxic-hyperoxic preconditioning before the surgery (HHP group) and the control group (without preconditioning). Safety control of the preconditioning procedure included ECG monitoring, invasive blood pressure, cardiac output, pulse oximetry, capnography, cerebral oximetry, measurement of anaerobic threshold; acid-base status and metabolic state of arterial and venous blood were assessed once every 10 min during the preconditioning procedure; oxygen balance parameters were calculated. Seventy-two hours before the surgery, an anaerobic threshold was determined to establish a safe oxygen concentration in the respiratory gas mixture during the hypoxic preconditioning phase from 10 to 14%, followed by 75-80% oxygen concentration during the hyperoxic phase.
The hypoxic-hyperoxic preconditioning with individual parameters selection based on the anaerobic threshold in patients with coronary artery diseases before the main stage of cardiac surgery with a cardiopulmonary bypass should reduce the duration of mechanical ventilation, catecholamine support, and frequency of perioperative complications.
57 studies on the registry are indexed under Myocardial Reperfusion Injury; 6 are open to participants now.
This study's enrollment of 120 is above the median of 81 across 46 interventional studies indexed under Myocardial Reperfusion Injury.
Browse Myocardial Reperfusion Injury studies →Alexander Averyanov is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
HHP was carried out as follows: breathing with a hypoxic gas mixture for 10 min with the development of hypoxemia, then breathing with a hyperoxic gas mixture for 30 minutes, and at the last stage, a period of breathing with atmospheric air until the cardio-pulmonary bypass is connected. The anaerobic threshold was determined 72 hours before surgery to establish a safe oxygen concentration in the respiratory gas mixture during the hypoxic phase of preconditioning.
Procedure: Hypoxic-hyperoxic preconditioning
The anaerobic threshold was determined, however, patients in the control group were not preconditioned. Mechanical ventilation was carried out with individual settings maintaining the target values of PaO2 and PaCO2 (80 - 120 mm Hg and 35 - 45 mm Hg, respectively), until the cardio-pulmonary bypass was connected.
Procedure: Placebo
Patients were intubated and mechanically ventilated with the target values of PaO2 and PaCO2 (80 - 120 mm Hg and 35 - 45 mm Hg, respectively) under the inhalation anesthesia. HHP was carried out as follows: breathing with a hypoxic gas mixture for 10 min with the development of hypoxemia, then breathing with a hyperoxic gas mixture for 30 minutes, then a period of breathing with atmospheric air (normoxia and normocapnia) until the cardio-pulmonary bypass is connected.
Also known as: HHP
Patients were intubated and mechanically ventilated with the target values of PaO2 and PaCO2 (80 - 120 mm Hg and 35 - 45 mm Hg, respectively) under the inhalation anesthesia until the cardio-pulmonary bypass is connected.
Number of Participants with complications
Any type of complications in postoperative period
Time frame: 60 days
Mechanical ventilation
Mechanical ventilation time
Time frame: 60 days
Rate of spontaneous sinus rhythm recovery
Spontaneous sinus rhythm recovery after surgery
Time frame: 14 days
Catecholamine support
Catecholamine support time
Time frame: 60 days
Troponin T
Troponin T concentration
Time frame: 12 hours
Endothelin-1
Endothelin-1 concentrations
Time frame: 1 day before surgery
Endothelin-1 dynamics 1
Endothelin-1 concentrations
Time frame: at the end of surgery
Endothelin-1 dynamics 2
Endothelin-1 concentrations
Time frame: 24 hours after surgery
NOx total
NOx total concentrations
Time frame: 1 day before surgery
NOx total dynamics 1
NOx total concentrations
Time frame: at the end of surgery
NOx total dynamics 2
NOx total concentrations
Time frame: 24 hours after surgery
Asymmetric dimethylarginine (ADMA)
ADMA concentrations
Time frame: 1 day before surgery
ADMA dymanics 1
ADMA concentrations
Time frame: at the end of surgery
ADMA dymanics 2
ADMA concentrations
Time frame: 24 hours after surgery
No study locations are listed for this record.
This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Myocardial Reperfusion Injury →
Alexander Averyanov